Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

FDA Approves Pfizer’s RSV Vaccine for Adults 60 and Older

Though agency advisers had some safety concerns, the Pfizer shot is expected to be available before the winter R.S.V. season.

Christina Jewett
Author: Christina Jewett

Written by

Christina Jewett

in

Centers for Disease Control and Prevention, Drugs (Pharmaceuticals), Elderly, Food and Drug Administration, GSK PLC, Guillain-Barre Syndrome, Pfizer Inc, Respiratory Syncytial Virus (RSV), Vaccination and Immunization, Viruses
←Amanda Gorman’s Book Sales Soar Amid Florida Bans Of Her Work
Conservatives Complain Chick-fil-A Has ‘Gone Woke’ Over D.E.I.→

More posts

  • Bob Iger’s New Magic Kingdom: Fans & Media Wonder If He Can Bring That Disney Sparkle To The Lakers

  • Photos: See the best photos from the solar eclipse

  • Ebola outbreak on track to be deadliest ever, WHO chief says

  • Jeremy Strong Emailed Mark Zuckerberg To Assure Him He Takes ‘The Social Reckoning’ Role “Very Seriously”

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube